APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nuclear Medicine Software

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Nuclear Medicine Software Market Analysis and Forecast 2026-2032

22 January 2026191 pages

Choose your research edition.

Industry ResearchNuclear Medicine Software Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Nuclear Medicine Software Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Nuclear Medicine Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nuclear Medicine Software Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Nuclear Medicine Software Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Nuclear Medicine Software market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Nuclear Medicine Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Nuclear Medicine Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Nuclear Medicine Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Nuclear Medicine Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Nuclear Medicine Software include iQ IMAGE, Mediso, Segami, Hermes Medical Solutions, MIM Software Inc, LabLogic, scintido, Gamma Gurus and Mirion Medical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Nuclear Medicine Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Nuclear Medicine Software, also provides the revenue of main regions and countries. Of the upcoming market potential for Nuclear Medicine Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nuclear Medicine Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Nuclear Medicine Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Nuclear Medicine Software revenue, projected growth trends, production technology, application and end-user industry.

Nuclear Medicine Software Segment by Company

iQ IMAGE

Mediso

Segami

Hermes Medical Solutions

MIM Software Inc

LabLogic

scintido

Gamma Gurus

Mirion Medical

PAIRE

GE HealthCare

Inter Medical

Sirona

Nuclear Medicine Software Segment by Type

Drug Management

Radiation Management

Other

Nuclear Medicine Software Segment by Application

Clinical Diagnosis

Research

Others

Nuclear Medicine Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nuclear Medicine Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nuclear Medicine Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nuclear Medicine Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Nuclear Medicine Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Nuclear Medicine Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nuclear Medicine Software revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Nuclear Medicine Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Drug Management Major Player Table 3. Radiation Management Major Player Table 4. Other Major Player Table 5. Global Nuclear Medicine Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Clinical Diagnosis Major Player Table 7. Research Major Player Table 8. Others Major Player Table 9. Nuclear Medicine Software Industry Trends Table 10. Nuclear Medicine Software Industry Drivers Table 11. Nuclear Medicine Software Industry Opportunities and Challenges Table 12. Nuclear Medicine Software Industry Restraints Table 13. Global Nuclear Medicine Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Nuclear Medicine Software Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Nuclear Medicine Software Market Share by Region (2021-2026) Table 16. Global Nuclear Medicine Software Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Nuclear Medicine Software Market Share by Region (2027-2032) Table 18. Global Nuclear Medicine Software Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Nuclear Medicine Software Revenue Market Share by Players (2021-2026) Table 20. Global Nuclear Medicine Software Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Nuclear Medicine Software Key Players Headquarters & Area Served Table 22. Global Nuclear Medicine Software Players, Product Type & Application Table 23. Global Nuclear Medicine Software Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Nuclear Medicine Software by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Nuclear Medicine Software Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Nuclear Medicine Software Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Nuclear Medicine Software Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Nuclear Medicine Software Revenue Market Share by Type (2021-2026) Table 30. Global Nuclear Medicine Software Revenue Market Share by Type (2027-2032) Table 31. Global Nuclear Medicine Software Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Nuclear Medicine Software Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Nuclear Medicine Software Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Nuclear Medicine Software Revenue Market Share by Application (2021-2026) Table 35. Global Nuclear Medicine Software Revenue Market Share by Application (2027-2032) Table 36. iQ IMAGE Company Information Table 37. iQ IMAGE Business Overview Table 38. iQ IMAGE Nuclear Medicine Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. iQ IMAGE Nuclear Medicine Software Product Portfolio Table 40. iQ IMAGE Recent Development Table 41. Mediso Company Information Table 42. Mediso Business Overview Table 43. Mediso Nuclear Medicine Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Mediso Nuclear Medicine Software Product Portfolio Table 45. Mediso Recent Development Table 46. Segami Company Information Table 47. Segami Business Overview Table 48. Segami Nuclear Medicine Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Segami Nuclear Medicine Software Product Portfolio Table 50. Segami Recent Development Table 51. Hermes Medical Solutions Company Information Table 52. Hermes Medical Solutions Business Overview Table 53. Hermes Medical Solutions Nuclear Medicine Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Hermes Medical Solutions Nuclear Medicine Software Product Portfolio Table 55. Hermes Medical Solutions Recent Development Table 56. MIM Software Inc Company Information Table 57. MIM Software Inc Business Overview Table 58. MIM Software Inc Nuclear Medicine Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. MIM Software Inc Nuclear Medicine Software Product Portfolio Table 60. MIM Software Inc Recent Development Table 61. LabLogic Company Information Table 62. LabLogic Business Overview Table 63. LabLogic Nuclear Medicine Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. LabLogic Nuclear Medicine Software Product Portfolio Table 65. LabLogic Recent Development Table 66. scintido Company Information Table 67. scintido Business Overview Table 68. scintido Nuclear Medicine Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. scintido Nuclear Medicine Software Product Portfolio Table 70. scintido Recent Development Table 71. Gamma Gurus Company Information Table 72. Gamma Gurus Business Overview Table 73. Gamma Gurus Nuclear Medicine Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Gamma Gurus Nuclear Medicine Software Product Portfolio Table 75. Gamma Gurus Recent Development Table 76. Mirion Medical Company Information Table 77. Mirion Medical Business Overview Table 78. Mirion Medical Nuclear Medicine Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Mirion Medical Nuclear Medicine Software Product Portfolio Table 80. Mirion Medical Recent Development Table 81. PAIRE Company Information Table 82. PAIRE Business Overview Table 83. PAIRE Nuclear Medicine Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. PAIRE Nuclear Medicine Software Product Portfolio Table 85. PAIRE Recent Development Table 86. GE HealthCare Company Information Table 87. GE HealthCare Business Overview Table 88. GE HealthCare Nuclear Medicine Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. GE HealthCare Nuclear Medicine Software Product Portfolio Table 90. GE HealthCare Recent Development Table 91. Inter Medical Company Information Table 92. Inter Medical Business Overview Table 93. Inter Medical Nuclear Medicine Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Inter Medical Nuclear Medicine Software Product Portfolio Table 95. Inter Medical Recent Development Table 96. Sirona Company Information Table 97. Sirona Business Overview Table 98. Sirona Nuclear Medicine Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Sirona Nuclear Medicine Software Product Portfolio Table 100. Sirona Recent Development Table 101. North America Nuclear Medicine Software Revenue by Type (2021-2026) & (US$ Million) Table 102. North America Nuclear Medicine Software Revenue by Type (2027-2032) & (US$ Million) Table 103. North America Nuclear Medicine Software Revenue by Application (2021-2026) & (US$ Million) Table 104. North America Nuclear Medicine Software Revenue by Application (2027-2032) & (US$ Million) Table 105. North America Nuclear Medicine Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. North America Nuclear Medicine Software Revenue by Country (2021-2026) & (US$ Million) Table 107. North America Nuclear Medicine Software Revenue by Country (US$ Million) & (2027-2032) Table 108. Europe Nuclear Medicine Software Revenue by Type (2021-2026) & (US$ Million) Table 109. Europe Nuclear Medicine Software Revenue by Type (2027-2032) & (US$ Million) Table 110. Europe Nuclear Medicine Software Revenue by Application (2021-2026) & (US$ Million) Table 111. Europe Nuclear Medicine Software Revenue by Application (2027-2032) & (US$ Million) Table 112. Europe Nuclear Medicine Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Europe Nuclear Medicine Software Revenue by Country (2021-2026) & (US$ Million) Table 114. Europe Nuclear Medicine Software Revenue by Country (US$ Million) & (2027-2032) Table 115. China Nuclear Medicine Software Revenue by Type (2021-2026) & (US$ Million) Table 116. China Nuclear Medicine Software Revenue by Type (2027-2032) & (US$ Million) Table 117. China Nuclear Medicine Software Revenue by Application (2021-2026) & (US$ Million) Table 118. China Nuclear Medicine Software Revenue by Application (2027-2032) & (US$ Million) Table 119. Asia Nuclear Medicine Software Revenue by Type (2021-2026) & (US$ Million) Table 120. Asia Nuclear Medicine Software Revenue by Type (2027-2032) & (US$ Million) Table 121. Asia Nuclear Medicine Software Revenue by Application (2021-2026) & (US$ Million) Table 122. Asia Nuclear Medicine Software Revenue by Application (2027-2032) & (US$ Million) Table 123. Asia Nuclear Medicine Software Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 124. Asia Nuclear Medicine Software Revenue by Region (US$ Million) & (2021-2026) Table 125. Asia Nuclear Medicine Software Revenue by Region (US$ Million) & (2027-2032) Table 126. SAMEA Nuclear Medicine Software Revenue by Type (2021-2026) & (US$ Million) Table 127. SAMEA Nuclear Medicine Software Revenue by Type (2027-2032) & (US$ Million) Table 128. SAMEA Nuclear Medicine Software Revenue by Application (2021-2026) & (US$ Million) Table 129. SAMEA Nuclear Medicine Software Revenue by Application (2027-2032) & (US$ Million) Table 130. SAMEA Nuclear Medicine Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. SAMEA Nuclear Medicine Software Revenue by Country (2021-2026) & (US$ Million) Table 132. SAMEA Nuclear Medicine Software Revenue by Country (US$ Million) & (2027-2032) Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Nuclear Medicine Software Image Figure 2. Global Nuclear Medicine Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nuclear Medicine Software Market Size Share 2021 VS 2025 VS 2032 Figure 4. Drug Management Image Figure 5. Radiation Management Image Figure 6. Other Image Figure 7. Global Nuclear Medicine Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Nuclear Medicine Software Market Size Share 2021 VS 2025 VS 2032 Figure 9. Clinical Diagnosis Image Figure 10. Research Image Figure 11. Others Image Figure 12. Global Nuclear Medicine Software Market Size (US$ Million) & (2021-2032) Figure 13. Global Nuclear Medicine Software Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Nuclear Medicine Software Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Nuclear Medicine Software Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Nuclear Medicine Software Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Nuclear Medicine Software Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Nuclear Medicine Software Revenue Market Share by Type (2021-2032) Figure 20. Global Nuclear Medicine Software Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Nuclear Medicine Software Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Nuclear Medicine Software Revenue Market Share by Application (2021-2032) Figure 23. North America Nuclear Medicine Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Nuclear Medicine Software Revenue Share by Type (2021-2032) Figure 25. North America Nuclear Medicine Software Revenue Share by Application (2021-2032) Figure 26. North America Nuclear Medicine Software Revenue Share by Country (2021-2032) Figure 27. United States Nuclear Medicine Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Nuclear Medicine Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Nuclear Medicine Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Nuclear Medicine Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Nuclear Medicine Software Revenue Share by Type (2021-2032) Figure 32. Europe Nuclear Medicine Software Revenue Share by Application (2021-2032) Figure 33. Europe Nuclear Medicine Software Revenue Share by Country (2021-2032) Figure 34. Germany Nuclear Medicine Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Nuclear Medicine Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Nuclear Medicine Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Nuclear Medicine Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Nuclear Medicine Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Nuclear Medicine Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Nuclear Medicine Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Nuclear Medicine Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Nuclear Medicine Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Nuclear Medicine Software Revenue Share by Type (2021-2032) Figure 44. China Nuclear Medicine Software Revenue Share by Application (2021-2032) Figure 45. Asia Nuclear Medicine Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Nuclear Medicine Software Revenue Share by Type (2021-2032) Figure 47. Asia Nuclear Medicine Software Revenue Share by Application (2021-2032) Figure 48. Asia Nuclear Medicine Software Revenue Share by Region (2021-2032) Figure 49. Japan Nuclear Medicine Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Nuclear Medicine Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Nuclear Medicine Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Nuclear Medicine Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Nuclear Medicine Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Nuclear Medicine Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Nuclear Medicine Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Nuclear Medicine Software Revenue Share by Type (2021-2032) Figure 57. SAMEA Nuclear Medicine Software Revenue Share by Application (2021-2032) Figure 58. SAMEA Nuclear Medicine Software Revenue Share by Country (2021-2032) Figure 59. Brazil Nuclear Medicine Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Nuclear Medicine Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Nuclear Medicine Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Nuclear Medicine Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Nuclear Medicine Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Nuclear Medicine Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Nuclear Medicine Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Nuclear Medicine Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Nuclear Medicine Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Nuclear Medicine Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Nuclear Medicine Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Drug Management
  • Radiation Management
  • Other
Applications
  • Clinical Diagnosis
  • Research
  • Others
Companies covered
  • iQ IMAGE
  • Mediso
  • Segami
  • Hermes Medical Solutions
  • MIM Software Inc
  • LabLogic
  • scintido
  • Gamma Gurus
  • Mirion Medical
  • PAIRE
  • GE HealthCare
  • Inter Medical
  • Sirona

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Nuclear Medicine Software Market by Type
  3. 1.2.1 Global Nuclear Medicine Software Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Drug Management
  5. 1.2.3 Radiation Management
  6. 1.2.4 Other
  7. 1.3 Nuclear Medicine Software Market by Application
  8. 1.3.1 Global Nuclear Medicine Software Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Clinical Diagnosis
  10. 1.3.3 Research
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Nuclear Medicine Software Market Dynamics
  1. 2.1 Nuclear Medicine Software Industry Trends
  2. 2.2 Nuclear Medicine Software Industry Drivers
  3. 2.3 Nuclear Medicine Software Industry Opportunities and Challenges
  4. 2.4 Nuclear Medicine Software Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Nuclear Medicine Software Market Perspective (2021-2032)
  2. 3.2 Global Nuclear Medicine Software Growth Trends by Region
  3. 3.2.1 Global Nuclear Medicine Software Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Nuclear Medicine Software Market Size by Region (2021-2026)
  5. 3.2.3 Global Nuclear Medicine Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Nuclear Medicine Software Revenue by Players
  2. 4.1.1 Global Nuclear Medicine Software Revenue by Players (2021-2026)
  3. 4.1.2 Global Nuclear Medicine Software Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Nuclear Medicine Software Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Nuclear Medicine Software Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Nuclear Medicine Software Key Players Headquarters & Area Served
  7. 4.4 Global Nuclear Medicine Software Players, Product Type & Application
  8. 4.5 Global Nuclear Medicine Software Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Nuclear Medicine Software Market CR5 and HHI
  11. 4.6.3 2025 Nuclear Medicine Software Tier 1, Tier 2, and Tier 3
5 Nuclear Medicine Software Market Size by Type
  1. 5.1 Global Nuclear Medicine Software Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Nuclear Medicine Software Revenue by Type (2021-2032)
  3. 5.3 Global Nuclear Medicine Software Revenue Market Share by Type (2021-2032)
6 Nuclear Medicine Software Market Size by Application
  1. 6.1 Global Nuclear Medicine Software Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Nuclear Medicine Software Revenue by Application (2021-2032)
  3. 6.3 Global Nuclear Medicine Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 iQ IMAGE
  2. 7.1.1 iQ IMAGE Company Information
  3. 7.1.2 iQ IMAGE Business Overview
  4. 7.1.3 iQ IMAGE Nuclear Medicine Software Revenue and Gross Margin (2021-2026)
  5. 7.1.4 iQ IMAGE Nuclear Medicine Software Product Portfolio
  6. 7.1.5 iQ IMAGE Recent Developments
  7. 7.2 Mediso
  8. 7.2.1 Mediso Company Information
  9. 7.2.2 Mediso Business Overview
  10. 7.2.3 Mediso Nuclear Medicine Software Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Mediso Nuclear Medicine Software Product Portfolio
  12. 7.2.5 Mediso Recent Developments
  13. 7.3 Segami
  14. 7.3.1 Segami Company Information
  15. 7.3.2 Segami Business Overview
  16. 7.3.3 Segami Nuclear Medicine Software Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Segami Nuclear Medicine Software Product Portfolio
  18. 7.3.5 Segami Recent Developments
  19. 7.4 Hermes Medical Solutions
  20. 7.4.1 Hermes Medical Solutions Company Information
  21. 7.4.2 Hermes Medical Solutions Business Overview
  22. 7.4.3 Hermes Medical Solutions Nuclear Medicine Software Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Hermes Medical Solutions Nuclear Medicine Software Product Portfolio
  24. 7.4.5 Hermes Medical Solutions Recent Developments
  25. 7.5 MIM Software Inc
  26. 7.5.1 MIM Software Inc Company Information
  27. 7.5.2 MIM Software Inc Business Overview
  28. 7.5.3 MIM Software Inc Nuclear Medicine Software Revenue and Gross Margin (2021-2026)
  29. 7.5.4 MIM Software Inc Nuclear Medicine Software Product Portfolio
  30. 7.5.5 MIM Software Inc Recent Developments
  31. 7.6 LabLogic
  32. 7.6.1 LabLogic Company Information
  33. 7.6.2 LabLogic Business Overview
  34. 7.6.3 LabLogic Nuclear Medicine Software Revenue and Gross Margin (2021-2026)
  35. 7.6.4 LabLogic Nuclear Medicine Software Product Portfolio
  36. 7.6.5 LabLogic Recent Developments
  37. 7.7 scintido
  38. 7.7.1 scintido Company Information
  39. 7.7.2 scintido Business Overview
  40. 7.7.3 scintido Nuclear Medicine Software Revenue and Gross Margin (2021-2026)
  41. 7.7.4 scintido Nuclear Medicine Software Product Portfolio
  42. 7.7.5 scintido Recent Developments
  43. 7.8 Gamma Gurus
  44. 7.8.1 Gamma Gurus Company Information
  45. 7.8.2 Gamma Gurus Business Overview
  46. 7.8.3 Gamma Gurus Nuclear Medicine Software Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Gamma Gurus Nuclear Medicine Software Product Portfolio
  48. 7.8.5 Gamma Gurus Recent Developments
  49. 7.9 Mirion Medical
  50. 7.9.1 Mirion Medical Company Information
  51. 7.9.2 Mirion Medical Business Overview
  52. 7.9.3 Mirion Medical Nuclear Medicine Software Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Mirion Medical Nuclear Medicine Software Product Portfolio
  54. 7.9.5 Mirion Medical Recent Developments
  55. 7.10 PAIRE
  56. 7.10.1 PAIRE Company Information
  57. 7.10.2 PAIRE Business Overview
  58. 7.10.3 PAIRE Nuclear Medicine Software Revenue and Gross Margin (2021-2026)
  59. 7.10.4 PAIRE Nuclear Medicine Software Product Portfolio
  60. 7.10.5 PAIRE Recent Developments
  61. 7.11 GE HealthCare
  62. 7.11.1 GE HealthCare Company Information
  63. 7.11.2 GE HealthCare Business Overview
  64. 7.11.3 GE HealthCare Nuclear Medicine Software Revenue and Gross Margin (2021-2026)
  65. 7.11.4 GE HealthCare Nuclear Medicine Software Product Portfolio
  66. 7.11.5 GE HealthCare Recent Developments
  67. 7.12 Inter Medical
  68. 7.12.1 Inter Medical Company Information
  69. 7.12.2 Inter Medical Business Overview
  70. 7.12.3 Inter Medical Nuclear Medicine Software Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Inter Medical Nuclear Medicine Software Product Portfolio
  72. 7.12.5 Inter Medical Recent Developments
  73. 7.13 Sirona
  74. 7.13.1 Sirona Company Information
  75. 7.13.2 Sirona Business Overview
  76. 7.13.3 Sirona Nuclear Medicine Software Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Sirona Nuclear Medicine Software Product Portfolio
  78. 7.13.5 Sirona Recent Developments
8 North America
  1. 8.1 North America Nuclear Medicine Software Revenue (2021-2032)
  2. 8.2 North America Nuclear Medicine Software Revenue by Type (2021-2032)
  3. 8.2.1 North America Nuclear Medicine Software Revenue by Type (2021-2026)
  4. 8.2.2 North America Nuclear Medicine Software Revenue by Type (2027-2032)
  5. 8.3 North America Nuclear Medicine Software Revenue Share by Type (2021-2032)
  6. 8.4 North America Nuclear Medicine Software Revenue by Application (2021-2032)
  7. 8.4.1 North America Nuclear Medicine Software Revenue by Application (2021-2026)
  8. 8.4.2 North America Nuclear Medicine Software Revenue by Application (2027-2032)
  9. 8.5 North America Nuclear Medicine Software Revenue Share by Application (2021-2032)
  10. 8.6 North America Nuclear Medicine Software Revenue by Country
  11. 8.6.1 North America Nuclear Medicine Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Nuclear Medicine Software Revenue by Country (2021-2026)
  13. 8.6.3 North America Nuclear Medicine Software Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Nuclear Medicine Software Revenue (2021-2032)
  2. 9.2 Europe Nuclear Medicine Software Revenue by Type (2021-2032)
  3. 9.2.1 Europe Nuclear Medicine Software Revenue by Type (2021-2026)
  4. 9.2.2 Europe Nuclear Medicine Software Revenue by Type (2027-2032)
  5. 9.3 Europe Nuclear Medicine Software Revenue Share by Type (2021-2032)
  6. 9.4 Europe Nuclear Medicine Software Revenue by Application (2021-2032)
  7. 9.4.1 Europe Nuclear Medicine Software Revenue by Application (2021-2026)
  8. 9.4.2 Europe Nuclear Medicine Software Revenue by Application (2027-2032)
  9. 9.5 Europe Nuclear Medicine Software Revenue Share by Application (2021-2032)
  10. 9.6 Europe Nuclear Medicine Software Revenue by Country
  11. 9.6.1 Europe Nuclear Medicine Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Nuclear Medicine Software Revenue by Country (2021-2026)
  13. 9.6.3 Europe Nuclear Medicine Software Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Nuclear Medicine Software Revenue (2021-2032)
  2. 10.2 China Nuclear Medicine Software Revenue by Type (2021-2032)
  3. 10.2.1 China Nuclear Medicine Software Revenue by Type (2021-2026)
  4. 10.2.2 China Nuclear Medicine Software Revenue by Type (2027-2032)
  5. 10.3 China Nuclear Medicine Software Revenue Share by Type (2021-2032)
  6. 10.4 China Nuclear Medicine Software Revenue by Application (2021-2032)
  7. 10.4.1 China Nuclear Medicine Software Revenue by Application (2021-2026)
  8. 10.4.2 China Nuclear Medicine Software Revenue by Application (2027-2032)
  9. 10.5 China Nuclear Medicine Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Nuclear Medicine Software Revenue (2021-2032)
  2. 11.2 Asia Nuclear Medicine Software Revenue by Type (2021-2032)
  3. 11.2.1 Asia Nuclear Medicine Software Revenue by Type (2021-2026)
  4. 11.2.2 Asia Nuclear Medicine Software Revenue by Type (2027-2032)
  5. 11.3 Asia Nuclear Medicine Software Revenue Share by Type (2021-2032)
  6. 11.4 Asia Nuclear Medicine Software Revenue by Application (2021-2032)
  7. 11.4.1 Asia Nuclear Medicine Software Revenue by Application (2021-2026)
  8. 11.4.2 Asia Nuclear Medicine Software Revenue by Application (2027-2032)
  9. 11.5 Asia Nuclear Medicine Software Revenue Share by Application (2021-2032)
  10. 11.6 Asia Nuclear Medicine Software Revenue by Country
  11. 11.6.1 Asia Nuclear Medicine Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Nuclear Medicine Software Revenue by Country (2021-2026)
  13. 11.6.3 Asia Nuclear Medicine Software Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Nuclear Medicine Software Revenue (2021-2032)
  2. 12.2 SAMEA Nuclear Medicine Software Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Nuclear Medicine Software Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Nuclear Medicine Software Revenue by Type (2027-2032)
  5. 12.3 SAMEA Nuclear Medicine Software Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Nuclear Medicine Software Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Nuclear Medicine Software Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Nuclear Medicine Software Revenue by Application (2027-2032)
  9. 12.5 SAMEA Nuclear Medicine Software Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Nuclear Medicine Software Revenue by Country
  11. 12.6.1 SAMEA Nuclear Medicine Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Nuclear Medicine Software Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Nuclear Medicine Software Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst